Eton Pharmaceuticals (ETON) EBITDA Margin (2019 - 2026)
Eton Pharmaceuticals' EBITDA Margin came in at 17.18% for Q4 2025, down 0.19 percentage points from 17.37% a year earlier but up 17.91 percentage points from the prior quarter.
Powered by 
Analysis
Eton Pharmaceuticals (ETON) EBITDA Margin (2019 - 2026) Analysis & Trends
For FY2025, Eton Pharmaceuticals' EBITDA Margin was 4.87%, up 5.75 percentage points from FY2024.
- EBITDA Margin carries a five-year change of +67540.77 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -0.88% in FY2024 (-0.33 pp), -0.55% in FY2023 (+29.37 pp), -29.92% in FY2022 (-25.87 pp) and -4.05% in FY2021 (+67531.84 pp).
- The five-year range for quarterly EBITDA Margin is -738.71% (Q3 2021) to 46.68% (Q1 2021).
- Year-over-year, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of +6.91 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q2 2021 (a gain of 21683.17 percentage points), and the weakest in Q1 2022 (a drop of 270.49 percentage points).
- Business Quant data shows ETON's EBITDA Margin at -0.73% (Q3 2025), -2.23% (Q2 2025) and 4.84% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Eton Pharmaceuticals | 1.91 Bn | 1.78 Bn | 44.30 Mn | 42.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 42.58% |
| Jun 30, 2026 | 38.15% |
| Mar 31, 2026 | 15.10% |
| Dec 31, 2025 | 17.18% |
| Sep 30, 2025 | -0.73% |
| Jun 30, 2025 | -2.23% |
| Mar 31, 2025 | 4.84% |
| Dec 31, 2024 | 17.37% |
| Sep 30, 2024 | 7.90% |
| Jun 30, 2024 | -29.02% |
| Mar 31, 2024 | -6.79% |
| Dec 31, 2023 | -22.44% |
| Sep 30, 2023 | -4.67% |
| Jun 30, 2023 | 34.07% |
| Mar 31, 2023 | -43.21% |
| Dec 31, 2022 | 15.83% |
| Sep 30, 2022 | -81.86% |
| Jun 30, 2022 | -1.89% |
| Mar 31, 2022 | -223.81% |
| Dec 31, 2021 | 24.44% |
API Access
Eton Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ETON&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ETON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ETON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();